Fairvalue-Calculator Fairvalue-Calculator
EN DE

Gossamer Bio, Inc (GOSS) Fair Value & Analysis

Healthcare · US · Market cap $82.1M

Price$0.1642
Fair Value$0.3500
Upside+113.2%
Quality95/100
Evidence: Low Range $0.2600 – $0.4300

Fair value as of: Jun 23, 2026

Analysis

Gossamer Bio, Inc (GOSS) currently trades at $0.1642, while our model-based Fair Value estimate is $0.3500 — implying the stock looks roughly 113.2% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is Gossamer Bio, Inc (GOSS) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.3500 versus a price of $0.1642 — about +113% (undervalued). Model-based estimate, not financial advice.
What is the fair value of GOSS?
Our 21-model fair value for Gossamer Bio, Inc is $0.3500 (as of Jun 23, 2026), built from audited fundamentals. The current price is $0.1642.
What is the quality score of GOSS?
Gossamer Bio, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.